Literature DB >> 28508207

New aspects of the Seam4D-dependent control of lymphocyte activation.

E M Kuklina1, I V Nekrasova2.   

Abstract

Novel targets for action of the class IV semaphorin Seam4D have been identified in the immune system. The low-affinity CD72 receptor for Seam4D was detected not only on B lymphocytes, but also in a proportion of T cells, whereas the high-affinity semaphorin receptor, plexin B1, originally considered to belong to non-immune cells, proved to be in a great proportion of intact T and B cells. Seam4D is constitutively expressed in B cells, which, along with T cells, can serve as a source of both membrane and soluble semaphorin. The results obtained make significant adjustments in understanding of Seam4D effects in lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28508207     DOI: 10.1134/S0012496617020028

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN: 0012-4966


  14 in total

1.  Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation.

Authors:  C Bougeret; I G Mansur; H Dastot; M Schmid; G Mahouy; A Bensussan; L Boumsell
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

Review 2.  Regulation of immune cell responses by semaphorins and their receptors.

Authors:  Hyota Takamatsu; Tatsusada Okuno; Atsushi Kumanogoh
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

3.  Role of B cells in presentation of autoantigens to CD4(+) T cells in patients with autoimmune thyroiditis.

Authors:  E M Kuklina; E N Smirnova; I V Nekrasova; T S Balashova
Journal:  Dokl Biol Sci       Date:  2015-11-04

4.  Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses.

Authors:  X Wang; A Kumanogoh; C Watanabe; W Shi; K Yoshida; H Kikutani
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

5.  Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.

Authors:  A Kumanogoh; C Watanabe; I Lee; X Wang; W Shi; H Araki; H Hirata; K Iwahori; J Uchida; T Yasui; M Matsumoto; K Yoshida; H Yakura; C Pan; J R Parnes; H Kikutani
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

6.  Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.

Authors:  L Tamagnone; S Artigiani; H Chen; Z He; G I Ming; H Song; A Chedotal; M L Winberg; C S Goodman; M Poo; M Tessier-Lavigne; P M Comoglio
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

7.  Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.

Authors:  Elizabeth E Evans; Alan S Jonason; Holm Bussler; Sebold Torno; Janaki Veeraraghavan; Christine Reilly; Michael A Doherty; Jennifer Seils; Laurie A Winter; Crystal Mallow; Renee Kirk; Alan Howell; Susan Giralico; Maria Scrivens; Katya Klimatcheva; Terrence L Fisher; William J Bowers; Mark Paris; Ernest S Smith; Maurice Zauderer
Journal:  Cancer Immunol Res       Date:  2015-01-22       Impact factor: 11.151

8.  The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal γδ T cell function.

Authors:  Deborah A Witherden; Megumi Watanabe; Olivia Garijo; Stephanie E Rieder; Gor Sarkisyan; Shane J F Cronin; Petra Verdino; Ian A Wilson; Atsushi Kumanogoh; Hitoshi Kikutani; Luc Teyton; Wolfgang H Fischer; Wendy L Havran
Journal:  Immunity       Date:  2012-08-16       Impact factor: 31.745

Review 9.  Sema 4D/CD100-plexin B is a multifunctional counter-receptor.

Authors:  Yusi Zhang; Bei Liu; Ying Ma; Boquan Jin
Journal:  Cell Mol Immunol       Date:  2012-12-24       Impact factor: 11.530

Review 10.  Immune semaphorins: novel features of neural guidance molecules.

Authors:  Masayuki Mizui; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.